Praxis Precision Medicines Inc (PRAX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $8.67B
Last updated: Nov 17, 2026 at 4:42 PM ET
Praxis Precision Medicines Inc (PRAX) Statistics
Praxis Precision Medicines (PRAX) has a market cap of $8.67B and an enterprise value of $8.31B. Its share count is up 32.77% from a year earlier. Revenue fell 100.00% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 4.17% below the market cap, as cash exceeds debt.
| Market Cap | $8.67B |
|---|---|
| Enterprise Value | $8.31B |
| Latest price (Nov 17, 2026) | $305.06 |
Key Dates
The next earnings report is expected on Feb 17, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 17, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 9, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is up 63.64% over 52 weeks and trades 5.88% above its 50-day average.
| Beta (1Y) | 1.58 |
|---|---|
| 52-Week Change | +63.64% |
| 1-Month Change | +17.25% |
| 3-Month Change | -21.01% |
| 6-Month Change | -4.85% |
| 5-Year Change | -8.31% |
| Total Return (1Y) | +63.64% |
| Total Return (3Y CAGR) | +170.22% |
| Total Return (5Y CAGR) | +1.61% |
| Return vs SPY (1Y) | +54.12% |
| Max Drawdown (1Y) | -38.13% |
| Max Drawdown (3Y) | -68.64% |
| Sharpe Ratio (1Y) | 0.69 |
| Correlation with SPY (1Y) | 0.30 |
| 50-Day Average | $288.12 |
| 200-Day Average | $314.54 |
| 52-Week Range | $160.11 to $392.70 |
| RSI (14 Days) | 53.1 |
| Average Volume (20 Days) | 478.21K |
The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 14.53x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 14.53x |
|---|---|
| Quick Ratio | 14.53x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -28.54% and return on assets is -27.39% over the last 12 months.
| Return on Equity (ROE) | -28.54% |
|---|---|
| Return on Assets (ROA) | -27.39% |
| Return on Capital Employed (ROCE) | -28.54% |
| ROA (5Y Average) | -90.66% |
| ROIC (5Y Average) | -27.28% |
Scores
PRAX has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 2 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Revenue Growth (YoY) | -100.00% |
| Gross Profit | -$28.00K |
| Operating Income | -$406.72M |
| Pretax Income | -$359.43M |
| Net Income | -$359.43M |
| EBIT | -$359.43M |
| Reported EPS (TTM) | -$12.80 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 96.18% of the $1.31B in total assets.
| Cash and Equivalents | $361.85M |
|---|---|
| Total Debt | $0 |
| Net Cash | $361.85M |
| Net Cash Per Share | $12.40 |
| Working Capital | $710.30M |
| Shareholder Equity | $1.26B |
| Book Value Per Share | $43.17 |
| Total Assets | $1.31B |
| Total Liabilities | $52.50M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $1.86M of capital spending, operating cash flow left -$323.62M of free cash flow.
| Operating Cash Flow | -$321.76M |
|---|---|
| Capital Expenditures | $1.86M |
| Free Cash Flow | -$323.62M |
| FCF Per Share | -$11.59 |
| Depreciation and Amortization | $2.16M |
Trailing 12 months through Sep 30, 2026.
Growth
| Book Value Per Share Growth (2Y CAGR) | +125.27% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | +125.27% |
Dividends and Yields
PRAX does not pay a dividend.
| Buyback Yield | -13.87% |
|---|---|
| Shareholder Yield | -13.87% |
Stock Splits
The last split was a 1-for-15 reverse split on Nov 29, 2023.
| Last Split Date | Nov 29, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PRAX
What is PRAX's market cap?
Praxis Precision Medicines has a market cap of $8.67B. Its enterprise value, which adds debt and subtracts cash, is $8.31B.
How many shares of PRAX are outstanding?
Praxis Precision Medicines has 29.18M shares outstanding. The count is up 32.77% from a year earlier.
Does PRAX pay a dividend?
No. Praxis Precision Medicines does not pay a dividend.
How much debt does PRAX have?
Praxis Precision Medicines has $0 of total debt and $361.85M of cash and equivalents, a net cash position of $361.85M.
PRAX pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors